1. 於全球具影響力的醫學期刊-The New England Journal of Medicine (NEJM)上發表Effectiveness of an Inactivated SARS-CoV-2 Vaccine論文，2021年impact factor達176.079，新竹馬偕醫院為當年度全國唯一在此期刊刊登與covid-19相關論文的醫療院所。Chi H, Chiu NC, Lin CY. Effectiveness of an Inactivated SARS-CoV-2 Vaccine. N Engl J Med. 2021 Sep 30;385(14):1337-1338. doi: 10.1056/NEJMc2112423. Epub 2021 Sep 15. PMID: 34525279.

2. 由於團隊於醫學期刊在新冠期間發表一些研究，引起國際關注，因此也受邀在APEC論壇，與美國、墨西哥、日本、韓國、智利、秘魯、印尼、泰國、菲律賓等各國專家一起線上討論covid-19照護的治療方針及建議，新竹馬偕醫院為全國唯一受邀加入論壇的醫療院所，後續論壇成果也發表在國際期刊。Jia, L., Beidelschies, M., Evans, J. M., Niemtzow, R. C., Zhou Niemtzow, S., Dusek, J. A., Lin, Y., Wu, C., Wang, C. J., Su, Y.-C., Lin, C.-Y., Astana, P. R. W., Ardiyanto, D., Hardjoutomo, R., Visithanon, K., Puagkong, J., Chokpaisarn, J., Villar Lopez, M., Yotsuyanagi, H., Lee, M. S., Garcia Ramirez, H. J., Plaza Bobadilla, C., Gonzalez Quinteros, E. M., Galanti de la Paz, M., Maramba-Lazarte, C. C., & APEC Health Working Group. (2024). Recommendations and guidelines of integrative medicine for COVID-19 care: The APEC project outcome. Integrative Medicine Research, 13(1), 101022. https://doi.org/10.1016/j.imr.2024.101022

3. 台灣的防疫成績斐然，團隊整理了台灣政府的防疫措施，包括邊境防疫、口罩政策等等，可提供其他國家防疫政策的參考。Chen, C.-C., Tseng, C.-Y., Choi, W.-M., Lee, Y.-C., Su, T.-H., Hsieh, C.-Y., Chang, C.-M., Weng, S.-L., Liu, P.-H., Tai, Y.-L., & Lin, C.-Y. (2020). Taiwan government-guided strategies contributed to combating and controlling COVID-19 pandemic. Frontiers in Public Health, 8, 1-7. https://doi.org/10.3389/fpubh.2020.547423

4. 台灣防疫的重要措施包括口罩政策、手部衛生、保持社交距離，這些政策除了對新冠有預防效果外，對其他疾病是否也有效?團隊運用疾管署的資料，發現新冠期間這些政策的推行，也有效降低肺炎、流感及腸病毒的流行，此項成果刊登在國際高分論文外，也獲得多次引用。Chiu, N.-C., Chi, H., Tai, Y.-L., Peng, C.-C., Tseng, C.-Y., Chen, C.-C., Tan, B. F., & Lin, C.-Y. (2020). Impact of wearing masks, hand hygiene, and social distancing on influenza, enterovirus, and all-cause pneumonia during the coronavirus pandemic: Retrospective national epidemiological surveillance study. JMIR Formative Research, 22(8), e21257. https://doi.org/10.2196/21257

5. 隨著疫苗開始施打，怎麼樣達到最好的疫苗保護力引起全世界關注，尤其一些報告發現混打線病毒載體疫苗跟mRNA疫苗可以達到最好的保護力，是否真的如此呢?因此團隊快速地整理文獻資料，發現混打疫苗的確可以提供更好、更久的保護力，因此順利刊登於高分國際雜誌Expert Review of Vaccines。Nan-Chang Chiu, Hsin Chi, Yu-Kang Tu, Ya-Ning Huang, Yu-Lin Tai, Shun- Long Weng, Lung Chang, Daniel Tsung-Ning Huang, Fu-Yuan Huang & Chien-Yu Lin. (2021). To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination, Expert Review of Vaccines, DOI: 10.1080/14760584.2021.1971522